A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells
Biotechnology and Bioengineering · 2026
DOI: 10.1002/bit.70298 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2026. Written by Shao Ying Tan and 2 co-authors. Institution: Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Suita, Japan. Major MEDLINE topics: Mesenchymal Stem Cells, Extracellular Matrix. 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Agency for Medical Research and Development.
Abstract (original language)
Reliable potency assays are critical for ensuring the therapeutic consistency and manufacturing quality of mesenchymal stem/stromal cells (MSCs). Conventional assays based on soluble factor quantification often fail to capture extracellular matrix (ECM) remodeling capacity and exhibit high variability. We developed a biologically relevant, image‐based potency assay that directly quantifies MSCs‐mediated ECM remodeling under defined biophysical conditions. A collagen‐coated (CL) surface that provides a stable, proliferation‐suppressive microenvironment, enabling single‐cell quantification of remodeling activity using collagen hybridizing peptide staining. The ECM remodeling index ( I CHP+ ) defined an optimal working range (3.0 × 10 3 ≤ cells/cm 2 ≤ 4.5 × 10 3 ), where spatially separated MSCs achieved high analytical precision (CV < 10%). The CL‐based assay demonstrated robust repeatability across MSCs sources and biologically relevant quantitation limits. Integration of I CHP+ with γH2AX, enabled simultaneous assessment of functional potency and cell health. Response surface methodology modeling of culture duration, seeding density, and passage number revealed a dome‐shaped relationship, with maximal remodeling at early passages ( N p 1– N p 3) and 3–5 days of culture, whereas extended culture (> 6 days) decreased potency alongside elevated γH2AX expression. The model exhibited strong predictive performance (R 2 > 0.95), supporting its utility for process optimization. Collectively, this mechanism‐based potency assay enables standardized platform for potency evaluation and manufacturing control for consistent, high‐quality MSCs therapeutics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Suita, Japan.
- Research Base for Cell Manufacturability, The University of Osaka, Suita, Japan.
ORCID profiles: Shao Ying Tan
Funding
- Japan Agency for Medical Research and Development
Cite
APA
Tan, S. Y., Kim, M. H., & Kino-Oka, M. (2026). A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70298
Vancouver
Tan SY, Kim MH, Kino-Oka M. A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70298
BibTeX
@article{Tan2026,
author = {Tan, Shao Ying and Kim, Mee-Hae and Kino-Oka, Masahiro},
title = {A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70298}
}
EUVIMED